Abstract
TRPV1, a novel biomarker associated with lung cancer via excluding immune infiltration.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1002/mco2.139
Copy DOIJournal: MedComm | Publication Date: May 23, 2022 |
Citations: 6 | License type: CC BY 4.0 |
TRPV1, a novel biomarker associated with lung cancer via excluding immune infiltration.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.